Viewing nowMD ESPAR 40mg (Esomeprazole Magnesium Trihydrate)
Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Arise Pharmaceutical Co., Ltd.

MFDS item code 201604557 · Approved 2016.07.22 · Insurance code 058200050
Treatment and prevention of acid-related disorders (such as reflux), ulcers, rebleeding, and gastrointestinal symptoms caused by anti-inflammatory analgesics
This medication is used for the treatment and maintenance of gastroesophageal reflux disease, especially erosive reflux esophagitis, to prevent recurrence. It is also effective in treating and preventing recurrence of duodenal ulcers and peptic ulcers, which are caused by Helicobacter pylori infection. It helps in the treatment and prevention of upper gastrointestinal symptoms and gastric and duodenal ulcers associated with NSAID use. It is applicable for the treatment of Zollinger-Ellison syndrome as well. Maintenance therapy is used after intravenous infusion to prevent gastric or duodenal ulcers from rebleeding. Overall, it is used for the treatment and prevention of various gastrointestinal-related disorders.
1. Adults 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis is not healed or symptoms persist, continue taking the drug for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms are relieved, control subsequent symptoms by administering 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed administration is not recommended for controlling recurring symptoms in patients at high risk of gastric and duodenal ulcers due to use of nonsteroidal anti-inflammatory drugs. 2) Antibiotic combination therapy for eradication of Helicobacter pylori Administer this drug 20 mg in combination with amoxicillin 1 g and clarithromycin 500 mg, 2 times daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with use of nonsteroidal anti-inflammatory drugs (COX-2 nonselective or selective) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical trials exceeding 4 weeks have not been conducted. 4) Patients requiring continuous treatment with nonsteroidal anti-inflammatory drugs - Treatment of gastric ulcers associated with use of nonsteroidal anti-inflammatory drugs: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with use of nonsteroidal anti-inflammatory drugs: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg 2 times daily. The dose should then be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses above 80 mg per day should be divided into 2 doses. 6) Maintenance therapy following induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous administration Administer 40 mg once daily for 4 weeks following induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous administration. 4. Renal impairment No dose adjustment is necessary. Use with caution because there is limited experience administering this drug to patients with severe renal failure. 5. Hepatic impairment No dose adjustment is necessary in patients with mild to moderate hepatic impairment. Patients with severe hepatic impairment should not exceed a dose of 20 mg of this drug. 6. Older adults No dose adjustment is necessary.
2. Adolescents aged 12 years and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis is not healed or symptoms persist, continue taking the drug for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms are relieved, control subsequent symptoms by administering 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed administration is not recommended for controlling recurring symptoms in patients at high risk of gastric and duodenal ulcers due to use of nonsteroidal anti-inflammatory drugs. 3. Children under 12 years There is no experience with administering this drug to children under 12 years.
This medication should not be administered to patients with known allergies or hypersensitivity to specific components. Additionally, caution is necessary as allergic reactions may occur when used in combination with certain antibiotics. It should not be taken by women who are nursing or patients with a history of myocardial infarction. While taking this medication, various adverse reactions may occur, and patients should be attentive to their symptoms. In particular, side effects may arise from various body systems including blood, immune, nervous, gastrointestinal, liver, skin, musculoskeletal, etc. Regular monitoring is necessary for long-term use, and if symptoms change during treatment, consulting a healthcare professional is essential. This medication may interact with other drugs, so it is important to inform healthcare providers if taking any other medications. Particularly, caution is required when used concomitantly with antiviral agents, antibiotics, and anticoagulants. For those who are pregnant, safety data regarding this medication is limited, so it must be taken according to a physician's instructions. Nursing mothers should avoid taking this medication, and in case of overdose, immediate contact with a medical facility is necessary as there is no specific antidote available. This medication should be kept out of reach of children and should not be transferred to other containers.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disturbance, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distention, allergic reaction, back pain, chest pain, substernal chest pain, facial edema, facial flushing, fatigue, fever, flu-like syndrome, generalized edema, leg swelling, malaise, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, thyroid nodules, irritable bowel syndrome, worsening constipation, dyspepsia, dysphagia, gastrointestinal dysmotility, upper abdominal pain, belching, esophageal disorders, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, black stools, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin, tongue disorders, tongue swelling, ulcerative stomatitis, earache, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, nosebleed, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, thirst, vitamin B12 deficiency, weight gain, weight loss, worsened arthritis, arthropathy, convulsions, fibromyalgia syndrome, hernia, rheumatoid polymyalgia, loss of appetite, apathy, increased appetite, confusion, worsened depression, hypertonia, sensory loss, erectile dysfunction, insomnia, migraine, worsened migraine, sleep disturbances, tremors, visual field defects, dysmenorrhea, menstrual disorders, vaginitis, worsened asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, altered olfaction, taste loss, taste distortion, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal pigmentation, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, hypocalcemia, hypokalemia, rhabdomyolysis, myalgia, elevated creatine kinase, increased myoglobin in blood and urine
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly closed container to prevent exposure to air or moisture. Additionally, it is important to store it in a cool room temperature, specifically between 1°C and 30°C, to maintain potency.
Pink, oval film-coated tablet
28T/Alu-Alu(14T/Alu-Alu*2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Arise Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.